Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Identifying Key Metrics and Analyzing Data on Performance Gaps Enhance MLR Review Processes

Data-driven analysis of key performance metrics can uncover hidden inefficiencies in MLR (medical, legal, and regulatory) review workflows for life sciences companies. By identifying and closing performance gaps, organizations can convert their compliance review processes from bottlenecks into competitive advantages. EY's approach emphasizes systematic measurement and continuous improvement within promotional material review.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By Annalise Ludtke · Jessy HorrellMlr ReviewPromotional Material Review ProcessPromotional Review Data
Share
Identifying Key Metrics and Analyzing Data on Performance Gaps Enhance MLR Review Processes

Key takeaways

01

Tracking the right KPIs in MLR review processes reveals workflow inefficiencies that are otherwise invisible to compliance teams.

02

Analyzing performance gaps enables life sciences companies to streamline promotional material approvals and reduce cycle times.

03

A data-driven MLR review strategy can reframe compliance from a cost center into a source of competitive differentiation.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Leveraging data to refine and enhance the promotional material review (MLR) process has become crucial in the ever-evolving landscape of life sciences. Organizations striving for efficiency and compliance need to understand how best to utilize available data to impact their workflow and overall success significantly.

Organizations striving for efficiency and compliance need to understand how best to utilize available data to impact their workflow and overall success significantly.

How can organizations use data to improve their MLR review processes? What specific metrics and insights should they focus on?

This episode of “Amend & Progress,” Vodori’s go-to podcast for all things promotional material features Jessy Horrell, VP of Customer Success at Vodori. She joins the host of the show, Annalise Ludtke to discuss the real-time analysis of promotional review data, uncovering insights and exploring how organizations can utilize this data to drive process improvements.

Key Points of Discussion

  • High-Level Metrics: Analyzing key performance indicators (KPIs) such as average job duration, feedback incorporation time, and review duration compared to industry benchmarks.
  • Workload Distribution: Understanding the distribution of tasks among reviewers and identifying potential bottlenecks or resource imbalances.
  • Performance Gaps: Identifying bottom performers and discussing strategies for supporting and improving their performance.

Jessy Horrell serves as the VP of Customer Success at Vodori, where she oversees customer onboarding and ongoing success with Vodori’s products. With a data-driven approach, Jessy helps clients understand and utilize their data to make informed decisions and enhance their MLR processes. Jessy holds a degree in Business Administration and has received numerous accolades for her contributions to customer success in the life sciences industry.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

AL
Annalise Ludtke

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

July partnerships show hospitals aligning without ownership change

July partnerships show hospitals aligning without ownership change

A July McDermott Will & Schulte analysis and four July partnership announcements tracked by Becker’s Hospital Review point to affiliation models that stop short of mergers. St. Christopher’s signed a nonbinding letter of intent with Nemours, Jefferson and Temple; Palomar UC San Diego Health began operating July 1 under a joint powers authority. Several announcements explicitly rule out ownership change, shifting the work to contracts covering governance and other terms.

  • 01In an alliance, the contract does the integrating that an org chart does in a merger: McDermott Will & Schulte says governance design, exclusivity, antitrust review, community commitments and exit rights all have to be settled before signing.
  • 02Purchasing is now explicitly on the table in at least one no-ownership deal, the St. Peter's Health and Billings Clinic-Logan Health talks in Montana, which means shared supply contracts can arrive without a change of control.

Sep 19, 2026

Eye telemedicine hits limits without home retinal imaging

Eye telemedicine hits limits without home retinal imaging

An Ophthalmology Times commentary by T.Y. Alvin Liu, Ferdinand Hui and Phillip Phan sorts eye patients into three telemedicine tiers by clinical need. Patients needing regular OCT scans benefit less unless a home device can send the image. Video tools already sit inside Epic and Cerner; the deciding purchase for retina clinics is the imaging device in the patient's living room.

  • 01The dividing line for eye telemedicine is imaging, not video: patients who need regular OCT scans benefit less from remote visits unless a device at home can send the scan, so a video license alone shifts few of those encounters.
  • 02The provider-side requirement, a HIPAA-compliant secured video platform, was already built into Epic and Cerner by 2020; the patient-side requirements (1.5 MB up and down bandwidth, a quiet private room, comfort with the technology) sit outside the health system's control and are the ones worth screening for at scheduling.
  • 03Self-administered home color fundus photography for tracking non-proliferative diabetic retinopathy was named as the nearer route into retina telemedicine; home OCT for wet AMD is the harder gate and the device to watch.

Sep 19, 2026

Value-based care reaches a quarter of revenue at 30% of surveyed health organizations

Value-based care reaches a quarter of revenue at 30% of surveyed health organizations

Wolters Kluwer Health argues value-based care software is judged on whether customers hit incentive thresholds and avoid penalties. A Fierce Healthcare-reported survey it cites puts value-based care at a quarter or more of revenue for 30% of organizations. The analysis is a vendor publication that ends by pitching its own UpToDate Connect API.

  • 01The sharper question for any population health or care coordination platform is whether it changes what a clinician does at the moment of decision, or only reports afterward what happened. Wolters Kluwer's reading of the evidence is that many platforms still struggle with the first.
  • 02Vendors selling into value-based contracts now face a build-or-license decision on clinical content, because Wolters Kluwer names current, trusted content, consistent clinician adoption across sites, and a traceable link from guidance to quality metrics as the three hard problems.

Sep 18, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

AL
Annalise Ludtke

Manager, Life Sciences Regulatory & Compliance at EY

Annalise Ludtke is a manager at EY specializing in life sciences regulatory and compliance. She focuses on optimizing medical, legal, and regulatory (MLR) review processes through data-driven methodologies. Her work helps pharmaceutical and biotech organizations transform compliance workflows into operational advantages.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512